8.045

2.71% 0.195

Iteos Therapeutics Inc (ITOS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$7.85

Aprire:

$7.8

Volume 24 ore:

707.21K

Relative Volume:

1.05

Capitalizzazione di mercato:

$286.79M

Reddito:

$127.70M

Utile/perdita netta:

$-108.14M

Rapporto P/E:

-9.811

EPS:

-0.82

Flusso di cassa netto:

$-117.52M

1 W Prestazione:

-4.70%

1M Prestazione:

-11.40%

6M Prestazione:

-55.28%

1 anno Prestazione:

-17.39%

Intervallo 1D:

$7.54

$8.23

Intervallo di 1 settimana:

$7.54

$8.58

Portata 52W:

$7.54

$18.75

Iteos Therapeutics Inc Stock (ITOS) Company Profile

Nome

Iteos Therapeutics Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

857-204-4583

Indirizzo

321 ARSENAL STREET, WATERTOWN

Dipendente

157

Cinguettio

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

ITOS's Discussions on Twitter

Confronta ITOS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ITOS	8.045	286.79M	127.70M	-108.14M	-117.52M	-0.82
VRTX	449.81	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	748.23	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	588.46	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.98	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.53	24.89B	3.30B	-501.07M	1.03B	11.54

Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-05-05	Iniziato	H.C. Wainwright	Buy
2020-10-08	Iniziato	Robert W. Baird	Outperform
2020-08-18	Iniziato	JP Morgan	Overweight
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-18	Iniziato	SVB Leerink	Outperform
2020-08-18	Iniziato	Wedbush	Outperform

Mostra tutto

Iteos Therapeutics Inc Borsa (ITOS) Ultime notizie

10:04 AM

Iteos Therapeutics stock hits 52-week low at $7.58 By Investing.com - Investing.com UK

10:04 AM

Nov 19, 2024

Insider Buying: Matthew Gall Acquires 5,000 Shares of ITeos Ther - GuruFocus.com

Nov 19, 2024

iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock By Investing.com - Investing.com UK

Nov 19, 2024

iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 19, 2024

Nov 16, 2024

Equities Analysts Offer Predictions for ITOS FY2024 Earnings - Defense World

Nov 16, 2024

US Bancorp DE Has $123,000 Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 16, 2024

Nov 15, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Simply Wall St

Nov 15, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 15, 2024

HC Wainwright Reaffirms Buy Rating for iTeos Therapeutics (NASDAQ:ITOS) - MarketBeat

Nov 15, 2024

Wedbush Reaffirms Outperform Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Nov 14, 2024

Nov 13, 2024

iTeos Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024

iTeos verkündet Finanzergebnisse für das dritte Quartal 2024 und gibt aktuelle Geschäftsinformationen bekannt - GlobeNewswire Inc.

Nov 13, 2024

Nov 12, 2024

Creative Planning Acquires 1,196 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 12, 2024

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 12, 2024

iTeos Reports Wider Q3 Loss, Maintains $684M Cash Runway Through 2027 | ITOS Stock News - StockTitan

Nov 12, 2024